211 related articles for article (PubMed ID: 12124864)
1. Study of the role of leukotriene B()4 in abnormal function of human subchondral osteoarthritis osteoblasts: effects of cyclooxygenase and/or 5-lipoxygenase inhibition.
Paredes Y; Massicotte F; Pelletier JP; Martel-Pelletier J; Laufer S; Lajeunesse D
Arthritis Rheum; 2002 Jul; 46(7):1804-12. PubMed ID: 12124864
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.
Martel-Pelletier J; Mineau F; Fahmi H; Laufer S; Reboul P; Boileau C; Lavigne M; Pelletier JP
Arthritis Rheum; 2004 Dec; 50(12):3925-33. PubMed ID: 15593193
[TBL] [Abstract][Full Text] [Related]
3. The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein.
Maxis K; Delalandre A; Martel-Pelletier J; Pelletier JP; Duval N; Lajeunesse D
Arthritis Res Ther; 2006; 8(6):R181. PubMed ID: 17156456
[TBL] [Abstract][Full Text] [Related]
4. The regulation of human MMP-13 by licofelone, an inhibitor of cyclo-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signalling pathway.
Boileau C; Pelletier JP; Tardif G; Fahmi H; Laufer S; Lavigne M; Martel-Pelletier J
Ann Rheum Dis; 2005 Jun; 64(6):891-8. PubMed ID: 15498796
[TBL] [Abstract][Full Text] [Related]
5. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis.
Hilal G; Martel-Pelletier J; Pelletier JP; Ranger P; Lajeunesse D
Arthritis Rheum; 1998 May; 41(5):891-9. PubMed ID: 9588742
[TBL] [Abstract][Full Text] [Related]
6. Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 in human osteoarthritic subchondral osteoblasts.
Hilal G; Martel-Pelletier J; Pelletier JP; Duval N; Lajeunesse D
Arthritis Rheum; 1999 Oct; 42(10):2112-22. PubMed ID: 10524682
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene and prostaglandin synthesis pathways in osteoarthritic synovial membranes: regulating factors for interleukin 1beta synthesis.
Marcouiller P; Pelletier JP; Guévremont M; Martel-Pelletier J; Ranger P; Laufer S; Reboul P
J Rheumatol; 2005 Apr; 32(4):704-12. PubMed ID: 15801029
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
[TBL] [Abstract][Full Text] [Related]
9. Treatment with licofelone prevents abnormal subchondral bone cell metabolism in experimental dog osteoarthritis.
Lajeunesse D; Martel-Pelletier J; Fernandes JC; Laufer S; Pelletier JP
Ann Rheum Dis; 2004 Jan; 63(1):78-83. PubMed ID: 14672896
[TBL] [Abstract][Full Text] [Related]
10. Endogenous prostaglandin E2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts.
Hilal G; Massicotte F; Martel-Pelletier J; Fernandes JC; Pelletier JP; Lajeunesse D
J Bone Miner Res; 2001 Apr; 16(4):713-21. PubMed ID: 11315999
[TBL] [Abstract][Full Text] [Related]
11. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of interleukin 1beta, tumor necrosis factor-alpha, and interstitial collagenase (MMP-1) is eicosanoid dependent in human osteoarthritis synovial membrane explants: interactions with antiinflammatory cytokines.
He W; Pelletier JP; Martel-Pelletier J; Laufer S; Di Battista JA
J Rheumatol; 2002 Mar; 29(3):546-53. PubMed ID: 11908571
[TBL] [Abstract][Full Text] [Related]
13. Biphasic positive effect of formononetin on metabolic activity of human normal and osteoarthritic subchondral osteoblasts.
Huh JE; Seo DM; Baek YH; Choi DY; Park DS; Lee JD
Int Immunopharmacol; 2010 Apr; 10(4):500-7. PubMed ID: 20138155
[TBL] [Abstract][Full Text] [Related]
14. Licofelone, a novel 5-LOX/COX-inhibitor, attenuates leukocyte rolling and adhesion on endothelium under flow.
Ulbrich H; Soehnlein O; Xie X; Eriksson EE; Lindbom L; Albrecht W; Laufer S; Dannhardt G
Biochem Pharmacol; 2005 Jul; 70(1):30-6. PubMed ID: 15894291
[TBL] [Abstract][Full Text] [Related]
15. Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis.
Alvaro-Gracia JM
Rheumatology (Oxford); 2004 Feb; 43 Suppl 1():i21-5. PubMed ID: 14752172
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and cathepsin K.
Pelletier JP; Boileau C; Brunet J; Boily M; Lajeunesse D; Reboul P; Laufer S; Martel-Pelletier J
Bone; 2004 Mar; 34(3):527-38. PubMed ID: 15003800
[TBL] [Abstract][Full Text] [Related]
17. Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis.
Vidal C; Gómez-Hernández A; Sánchez-Galán E; González A; Ortega L; Gómez-Gerique JA; Tuñón J; Egido J
J Pharmacol Exp Ther; 2007 Jan; 320(1):108-16. PubMed ID: 17015640
[TBL] [Abstract][Full Text] [Related]
18. Metabolic activity of osteoblasts from periprosthetic trabecular bone in failed total hip arthroplasties and osteoarthritis as markers of osteolysis and loosening.
Shi Q; Lajeunesse D; Reboul P; Martel-Pelletier J; Pelletier JP; Dehnade F; Fernandes JC
J Rheumatol; 2002 Jul; 29(7):1437-45. PubMed ID: 12136903
[TBL] [Abstract][Full Text] [Related]
19. Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide.
Mao JT; Tsu IH; Dubinett SM; Adams B; Sarafian T; Baratelli F; Roth MD; Serio KJ
Clin Cancer Res; 2004 Oct; 10(20):6872-8. PubMed ID: 15501964
[TBL] [Abstract][Full Text] [Related]
20. The lipoxygenase-cyclooxygenase inhibitor licofelone prevents thromboxane A2-mediated cardiovascular derangement triggered by the inflammatory peptide fMLP in the rabbit.
Rotondo S; Dell'Elba G; Manarini S; Cerletti C; Evangelista V
Eur J Pharmacol; 2006 Sep; 546(1-3):95-101. PubMed ID: 16920097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
